Logo image of AQNB

ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 (AQNB) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:AQNB - US0158578080

25.6 USD
+0.05 (+0.2%)
Last: 12/17/2025, 4:15:00 PM
Fundamental Rating

3

AQNB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 26 industry peers in the Multi-Utilities industry. While AQNB seems to be doing ok healthwise, there are quite some concerns on its profitability. AQNB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year AQNB was profitable.
AQNB had a positive operating cash flow in the past year.
In multiple years AQNB reported negative net income over the last 5 years.
In the past 5 years AQNB always reported a positive cash flow from operatings.
AQNB Yearly Net Income VS EBIT VS OCF VS FCFAQNB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

AQNB's Return On Assets of -0.27% is on the low side compared to the rest of the industry. AQNB is outperformed by 96.15% of its industry peers.
With a Return On Equity value of -0.80%, AQNB is not doing good in the industry: 96.15% of the companies in the same industry are doing better.
AQNB's Return On Invested Capital of 3.16% is on the low side compared to the rest of the industry. AQNB is outperformed by 88.46% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AQNB is in line with the industry average of 3.94%.
The 3 year average ROIC (2.36%) for AQNB is below the current ROIC(3.16%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.27%
ROE -0.8%
ROIC 3.16%
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
AQNB Yearly ROA, ROE, ROICAQNB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

The Operating Margin of AQNB (21.55%) is comparable to the rest of the industry.
AQNB's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 73.94%, AQNB is doing good in the industry, outperforming 73.08% of the companies in the same industry.
AQNB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.55%
PM (TTM) N/A
GM 73.94%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
AQNB Yearly Profit, Operating, Gross MarginsAQNB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

4

2. Health

2.1 Basic Checks

AQNB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AQNB has been increased compared to 1 year ago.
Compared to 5 years ago, AQNB has more shares outstanding
AQNB has a better debt/assets ratio than last year.
AQNB Yearly Shares OutstandingAQNB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
AQNB Yearly Total Debt VS Total AssetsAQNB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 1.31, we must say that AQNB is in the distress zone and has some risk of bankruptcy.
AQNB has a better Altman-Z score (1.31) than 96.15% of its industry peers.
AQNB has a Debt/Equity ratio of 1.33. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.33, AQNB is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.33
Debt/FCF N/A
Altman-Z 1.31
ROIC/WACC0.46
WACC6.85%
AQNB Yearly LT Debt VS Equity VS FCFAQNB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

AQNB has a Current Ratio of 1.23. This is a normal value and indicates that AQNB is financially healthy and should not expect problems in meeting its short term obligations.
AQNB has a better Current ratio (1.23) than 88.46% of its industry peers.
AQNB has a Quick Ratio of 1.03. This is a normal value and indicates that AQNB is financially healthy and should not expect problems in meeting its short term obligations.
AQNB has a Quick ratio of 1.03. This is amongst the best in the industry. AQNB outperforms 88.46% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.03
AQNB Yearly Current Assets VS Current LiabilitesAQNB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

AQNB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -29.79%.
AQNB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.38% yearly.
AQNB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -23.92%.
Measured over the past years, AQNB shows a small growth in Revenue. The Revenue has been growing by 7.38% on average per year.
EPS 1Y (TTM)-29.79%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-23.92%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%1.66%

3.2 Future

AQNB is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.09% yearly.
AQNB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.30% yearly.
EPS Next Y-12.26%
EPS Next 2Y-0.67%
EPS Next 3Y6.57%
EPS Next 5Y4.09%
Revenue Next Year-9.53%
Revenue Next 2Y-3.01%
Revenue Next 3Y-0.37%
Revenue Next 5Y2.3%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AQNB Yearly Revenue VS EstimatesAQNB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
AQNB Yearly EPS VS EstimatesAQNB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 77.58, the valuation of AQNB can be described as expensive.
AQNB's Price/Earnings ratio is rather expensive when compared to the industry. AQNB is more expensive than 96.15% of the companies in the same industry.
When comparing the Price/Earnings ratio of AQNB to the average of the S&P500 Index (26.43), we can say AQNB is valued expensively.
Based on the Price/Forward Earnings ratio of 70.13, the valuation of AQNB can be described as expensive.
AQNB's Price/Forward Earnings ratio is rather expensive when compared to the industry. AQNB is more expensive than 96.15% of the companies in the same industry.
AQNB's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.66.
Industry RankSector Rank
PE 77.58
Fwd PE 70.13
AQNB Price Earnings VS Forward Price EarningsAQNB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

AQNB's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. AQNB is more expensive than 96.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.54
AQNB Per share dataAQNB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.67%
EPS Next 3Y6.57%

6

5. Dividend

5.1 Amount

AQNB has a Yearly Dividend Yield of 4.51%, which is a nice return.
AQNB's Dividend Yield is rather good when compared to the industry average which is at 3.64. AQNB pays more dividend than 88.46% of the companies in the same industry.
AQNB's Dividend Yield is rather good when compared to the S&P500 average which is at 1.87.
Industry RankSector Rank
Dividend Yield 4.51%

5.2 History

The dividend of AQNB has a limited annual growth rate of 0.06%.
AQNB has been paying a dividend for over 5 years, so it has already some track record.
AQNB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.06%
Div Incr Years1
Div Non Decr Years4
AQNB Yearly Dividends per shareAQNB Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of AQNB are negative and hence is the payout ratio. AQNB will probably not be able to sustain this dividend level.
The dividend of AQNB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-569.86%
EPS Next 2Y-0.67%
EPS Next 3Y6.57%
AQNB Yearly Income VS Free CF VS DividendAQNB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079

NYSE:AQNB (12/17/2025, 4:15:00 PM)

25.6

+0.05 (+0.2%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)03-05 2026-03-05/amc
Inst Owners74.44%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap19.67B
Revenue(TTM)2.39B
Net Income(TTM)-37.22M
Analysts68.33
Price Target22.06 (-13.83%)
Short Float %0%
Short Ratio0.51
Dividend
Industry RankSector Rank
Dividend Yield 4.51%
Yearly Dividend0.41
Dividend Growth(5Y)0.06%
DP-569.86%
Div Incr Years1
Div Non Decr Years4
Ex-Date09-15 2025-09-15 (0.5412)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.46%
Min EPS beat(2)-0.69%
Max EPS beat(2)35.61%
EPS beat(4)2
Avg EPS beat(4)12.84%
Min EPS beat(4)-25.74%
Max EPS beat(4)42.17%
EPS beat(8)4
Avg EPS beat(8)5.61%
EPS beat(12)5
Avg EPS beat(12)1.98%
EPS beat(16)6
Avg EPS beat(16)-0.66%
Revenue beat(2)1
Avg Revenue beat(2)-0.52%
Min Revenue beat(2)-1.85%
Max Revenue beat(2)0.82%
Revenue beat(4)2
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)5.31%
Revenue beat(8)3
Avg Revenue beat(8)-1.75%
Revenue beat(12)6
Avg Revenue beat(12)-0.49%
Revenue beat(16)9
Avg Revenue beat(16)0.59%
PT rev (1m)11.44%
PT rev (3m)-1.98%
EPS NQ rev (1m)-18.84%
EPS NQ rev (3m)-17.05%
EPS NY rev (1m)3.27%
EPS NY rev (3m)3.69%
Revenue NQ rev (1m)-2.73%
Revenue NQ rev (3m)-3.47%
Revenue NY rev (1m)1.46%
Revenue NY rev (3m)1.72%
Valuation
Industry RankSector Rank
PE 77.58
Fwd PE 70.13
P/S 8.24
P/FCF N/A
P/OCF 42.23
P/B 4.24
P/tB 6.03
EV/EBITDA 28.54
EPS(TTM)0.33
EY1.29%
EPS(NY)0.37
Fwd EY1.43%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)0.61
OCFY2.37%
SpS3.11
BVpS6.04
TBVpS4.24
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.7
Profitability
Industry RankSector Rank
ROA -0.27%
ROE -0.8%
ROCE 4%
ROIC 3.16%
ROICexc 3.18%
ROICexgc 3.56%
OM 21.55%
PM (TTM) N/A
GM 73.94%
FCFM N/A
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
ROICexc(3y)2.37%
ROICexc(5y)2.33%
ROICexgc(3y)2.6%
ROICexgc(5y)2.56%
ROCE(3y)2.99%
ROCE(5y)2.93%
ROICexgc growth 3Y4.3%
ROICexgc growth 5Y-5.03%
ROICexc growth 3Y4.14%
ROICexc growth 5Y-4.63%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
F-Score4
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 1.33
Debt/FCF N/A
Debt/EBITDA 6.76
Cap/Depr 208.02%
Cap/Sales 34.55%
Interest Coverage 1.49
Cash Conversion 51.11%
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 1.03
Altman-Z 1.31
F-Score4
WACC6.85%
ROIC/WACC0.46
Cap/Depr(3y)213.94%
Cap/Depr(5y)245.17%
Cap/Sales(3y)39.89%
Cap/Sales(5y)45.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.79%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%12.5%
EPS Next Y-12.26%
EPS Next 2Y-0.67%
EPS Next 3Y6.57%
EPS Next 5Y4.09%
Revenue 1Y (TTM)-23.92%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%1.66%
Revenue Next Year-9.53%
Revenue Next 2Y-3.01%
Revenue Next 3Y-0.37%
Revenue Next 5Y2.3%
EBIT growth 1Y-15.87%
EBIT growth 3Y4.45%
EBIT growth 5Y4.06%
EBIT Next Year46.43%
EBIT Next 3Y20.94%
EBIT Next 5YN/A
FCF growth 1Y-47.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-27.45%
OCF growth 3Y45.17%
OCF growth 5Y-4.65%

ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 / AQNB FAQ

Can you provide the ChartMill fundamental rating for ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079?

ChartMill assigns a fundamental rating of 3 / 10 to AQNB.


What is the valuation status for AQNB stock?

ChartMill assigns a valuation rating of 0 / 10 to ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 (AQNB). This can be considered as Overvalued.


How profitable is ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 (AQNB) stock?

ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 (AQNB) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for AQNB stock?

The Earnings per Share (EPS) of ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 (AQNB) is expected to decline by -12.26% in the next year.


How sustainable is the dividend of ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 (AQNB) stock?

The dividend rating of ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 (AQNB) is 6 / 10 and the dividend payout ratio is -569.86%.